It was noted at Working Party meeting on the Treatment of Haemophiliacs that there was a shortfall of 3.5 million units of Factor 8 which it was agreed should be made up by commercial Factor 8. Read more about It was noted at Working Party meeting on the Treatment of Haemophiliacs that there was a shortfall of 3.5 million units of Factor 8 which it was agreed should be made up by commercial Factor 8.
The return for 1984 showed for the Queen Elizabeth Hospital that there was predominantly treatment with NHS concentrate and Factorate in both hospital and home settings. Read more about The return for 1984 showed for the Queen Elizabeth Hospital that there was predominantly treatment with NHS concentrate and Factorate in both hospital and home settings.
The Queen Elizabeth Hospital return for 1983 showed some treatment with cryoprecipitate in hospital but predominantly treatment with NHS concentrate and Factorate in both hospital and home settings. Read more about The Queen Elizabeth Hospital return for 1983 showed some treatment with cryoprecipitate in hospital but predominantly treatment with NHS concentrate and Factorate in both hospital and home settings.
The Working Party meeting did not result in any change of approach in regards to cryoprecipitate. Read more about The Working Party meeting did not result in any change of approach in regards to cryoprecipitate.
Dr Ala advised the West Midlands Working Party meeting - through letter - that cryoprecipitate was "probably a safer product than Factor VIII concentrate in respect of transmission of AIDS". Read more about Dr Ala advised the West Midlands Working Party meeting - through letter - that cryoprecipitate was "probably a safer product than Factor VIII concentrate in respect of transmission of AIDS".
Professor Franklin described in a letter how he and Professor Hill took the view that patients should have continuity in their factor product and given how erratic the NHS supply was it was better to keep them on commercial Factor VIII than switch between the two when NHS product was available. Read more about Professor Franklin described in a letter how he and Professor Hill took the view that patients should have continuity in their factor product and given how erratic the NHS supply was it was better to keep them on commercial Factor VIII than switch between the two when NHS product was available.
The UKHCDO recommended at the end of the 1983 meeting that patients did not switch from concentrates to cryo. Read more about The UKHCDO recommended at the end of the 1983 meeting that patients did not switch from concentrates to cryo.
At a Committee on Safety of Medicines Sub-Committee on Biological Products meeting, it was stated that the cause of AIDS was unknown. It was postulated that a new agent may have beeen responsible, but repeated exposure to, or reactivation of, known agents, (e.g. CMV, EBV) may have beeen involved. Read more about At a Committee on Safety of Medicines Sub-Committee on Biological Products meeting, it was stated that the cause of AIDS was unknown. It was postulated that a new agent may have beeen responsible, but repeated exposure to, or reactivation of, known agents, (e.g. CMV, EBV) may have beeen involved.
Figures relating to the annual consumption of commercial factor concentrate at different haemophilia centres between 1976 and 1994. Also included are the factor types, product names, haemophilia type, number of units and volume amounts. Read more about Figures relating to the annual consumption of commercial factor concentrate at different haemophilia centres between 1976 and 1994. Also included are the factor types, product names, haemophilia type, number of units and volume amounts.
In Glasgow Royal Infirmary, the 77 patients whose blood was tested for HIV as part of a study were not told that these tests were taking place. Read more about In Glasgow Royal Infirmary, the 77 patients whose blood was tested for HIV as part of a study were not told that these tests were taking place.